bioRxivCancer BiologyPreprint
A multi-scale segmentation-free self-supervised AI model to characterize the heterogeneity of the brain tumor microenvironment
Sam SterlingiD, Jimin TaniD, Hortense LeiD, Danielle Share, Yi Ban, Matija SnuderliD, Aristotelis TsirigosiD
Abstract
Brain tumors affect about 1 million people in the U.S., with aggressive types like glioblastoma having very low survival rates due to complex tumor biology and the protective blood-brain barrier. Current treatments are limited in effectiveness, and our understanding of brain tumor biology remains incomplete. High dimensional multiplexed imaging has enabled us to better understand the tumor microenvironment (TME); however, analyses typically rely on cell segmentation, which is error-prone, may discard useful context outside the cell boundary, and neglects complex tissue-wide features. To address this limitation, we developed a segmentation-free, self-supervised representation learning framework that enables us to train directly on multiplexed images using masked image modeling. We used this approach to analyze 389 imaging mass cytometry images from 185 brain tumor patients. To study tissue-wide features, we first trained our model on 64x64 micron tiles capturing neighborhoods of 10-20 cells, which we termed local tumor microenvironments (LTMEs). To further characterize these LTMEs, we trained our model on 16x16 micron tiles centered on individual cells in our dataset, so that each tile captures a single cell and its surrounding area, which we termed single-cell microenvironments (SCMEs). This multi-scale, self-supervised approach enables a detailed analysis of the heterogeneity within the brain TME, examining single cells in their spatial context. In addition to validating known findings, we identified a novel LTME in GBM patients, composed primarily of tumor cells and a few B and T cells, which strongly correlated with increased survival. By analyzing these B cells with our SCME model, we found they were distinct from other GBM B cells, and higher concentrations of these B cells were linked to improved survival. In conclusion, our study introduces a multi-scale, segmentation-free, self-supervised machine learning model that provides unprecedented insights into brain TMEs, enabling discovery of previously unrecognized cell interactions and spatial features that are predictive of patient survival.
- organism: human
- assay: imaging
- research focus: cell type annotation
- research focus: spatial domain detection
- approach: deep learning
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization of tumor heterogeneity through segmentation-free representation learning
Jimin Tan, Hortense Le, … David Fenyö·Nature Biomedical EngineeringPeer-reviewed·Feb 20, 2025
- BASSL-MI: Batch-Agnostic Self-Supervised Learning Uncovers Clinically Relevant Tumor Niches in Multiplexed Imaging
Alexander Lin, Shunxing Bao, … Siyuan Ma·IEEE International Symposium on Biomedical Imaging (ISBI)Peer-reviewed·Apr 8, 2026
- Fully Automated Brain Tumor Segmentation and Survival Prediction of Gliomas using Deep Learning and MRI
Chandan Ganesh Bangalore Yogananda, Ben C. Wagner, … Joseph A. Maldjian·Lecture notes in computer sciencePeer-reviewed·Jan 1, 2020
- Multidimensional and Multiresolution Ensemble Networks for Brain Tumor Segmentation
Gowtham Krishnan Murugesan, Sahil Sunil Nalawade, … Joseph A. Maldjian·bioRxiv·Sep 10, 2019
- Deep Learning Glioma Grading with the Tumor Microenvironment Analysis Protocol for A Comprehensive Learning, Discovering, and Quantifying Microenvironmental Features
Monika Pytlarz, Kamil Wojnicki, … Alessandro Crimi·Journal of Imaging Informatics in MedicinePeer-reviewed·Feb 27, 2024
- Self-supervised learning enables unbiased patient characterization from multiplexed cancer tissue microscopy images
Gantugs Atarsaikhan, Isabel Mogollón, … Lassi Paavolainen·bioRxiv·Mar 5, 2025